Artificial neural networks reveal sex differences in gene methylation, and connections between maternal risk factors and symptom severity in autism spectrum disorder

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. (Fifth Edition) (DSM-5). American Psychiatric Publishing, WA, USA (2013).
  Google Scholar
• 2. World Health Organization. Autism spectrum disorders (2022). www.who.int/news-room/fact-sheets/detail/autism-spectrum-disorders
  Google Scholar
• 3. Migliore L, Nicolì V, Stoccoro A. Gender specific differences in disease susceptibility: the role of epigenetics. Biomedicines 9(6), 652 (2021).
  Medline CASGoogle Scholar
• 4. Zeidan J, Fombonne E, Scorah J et al. Global prevalence of autism: a systematic review update. Autism Res. 15(5),778–790 (2022).
  MedlineGoogle Scholar
• 5. Maenner MJ, Shaw KA, Bakian AV et al. Prevalence and characteristics of autism spectrum disorder among children aged 8 years – Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2018. MMWR Surveill Summ. 70, 1–16 (2021).
  Google Scholar
• 6. Narzisi A, Posada M, Barbieri F et al. Prevalence of autism spectrum disorder in a large Italian catchment area: a school-based population study within the ASDEU project. Epidemiol. Psychiatr. Sci. 29, e5 (2018).
  Medline CASGoogle Scholar
• 7. Wiśniowiecka-Kowalnik B, Nowakowska BA. Genetics and epigenetics of autism spectrum disorder-current evidence in the field. J. Appl. Genet. 60(1), 37–47 (2019). • Interesting review of epigenetics of autism spectrum disorder.
  Medline CASGoogle Scholar
• 8. SFARI gene database. Human gene module (2021). https://gene.sfari.org/database/human-gene/
  Google Scholar
• 9. Pugsley K, Scherer SW, Bellgrove MA, Hawi Z. Environmental exposures associated with elevated risk for autism spectrum disorder may augment the burden of deleterious de novo mutations among probands. Mol. Psychiatry 27(1), 710–730 (2022).
  Medline CASGoogle Scholar
• 10. Coppedè F. The diagnostic potential of the epigenome in autism spectrum disorders. Epigenomics 13(20), 1587–1590 (2021).
  CASGoogle Scholar
• 11. Wilson KD, Porter EG, Garcia BA. Reprogramming of the epigenome in neurodevelopmental disorders. Crit. Rev. Biochem. Mol. Biol. 57(1), 73–112 (2022).
  Medline CASGoogle Scholar
• 12. Cao-Lei L, van den Heuvel MI, Huse K et al. Epigenetic modifications associated with maternal anxiety during pregnancy and children’s behavioral measures. Cells 10(9), 2421 (2021).
  Medline CASGoogle Scholar
• 13. Lee ASE, Ji Y, Raghavan R et al. Maternal prenatal selenium levels and child risk of neurodevelopmental disorders: a prospective birth cohort study. Autism Res. 14(12), 2533–2543 (2021).
  MedlineGoogle Scholar
• 14. Shirvani-Farsani Z, Maloum Z, Bagheri-Hosseinabadi Z, Vilor-Tejedor N, Sadeghi I. DNA methylation signature as a biomarker of major neuropsychiatric disorders. J. Psychiatr. Res. 141, 34–49 (2021).
  MedlineGoogle Scholar
• 15. Nagarajan RP, Hogart AR, Gwye Y, Martin MR, LaSalle JM. Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics 1(4), e1–e11 (2006).
  MedlineGoogle Scholar
• 16. Nagarajan RP, Patzel KA, Martin M et al. MECP2 promoter methylation and X chromosome inactivation in autism. Autism Res. 1(3), 169–178 (2008).
  MedlineGoogle Scholar
• 17. Gregory SG, Connelly JJ, Towers AJ et al. Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. BMC Med. 7, 62 (2009).
  MedlineGoogle Scholar
• 18. Elagoz Yuksel M, Yuceturk B, Karatas OF, Ozen M, Dogangun B. The altered promoter methylation of oxytocin receptor gene in autism. J. Neurogenet. 30(3–4), 280–284 (2016).
  MedlineGoogle Scholar
• 19. Andari E, Nishitani S, Kaundinya G et al. Epigenetic modification of the oxytocin receptor gene: implications for autism symptom severity and brain functional connectivity. Neuropsychopharmacology 45(7), 1150–1158 (2020).
  Medline CASGoogle Scholar
• 20. Siu MT, Goodman SJ, Yellan I et al. DNA methylation of the oxytocin receptor across neurodevelopmental disorders. J. Autism Dev. Disord. 51(10), 3610–3623 (2021).
  MedlineGoogle Scholar
• 21. Kundakovic M, Gudsnuk K, Herbstman JB, Tang D, Perera FP, Champagne FA. DNA methylation of BDNF as a biomarker of early-life adversity. Proc. Natl Acad. Sci. USA 112(22), 6807–6813 (2015).
  Medline CASGoogle Scholar
• 22. Berdasco M, Esteller M. Clinical epigenetics: seizing opportunities for translation. Nat. Rev. Genet. 20(2), 109–127 (2019).
  Medline CASGoogle Scholar
• 23. Lintas C, Sacco R, Persico AM. Differential methylation at the RELN gene promoter in temporal cortex from autistic and typically developing post-puberal subjects. J. Neurodev. Disord. 8, 18 (2016).
  MedlineGoogle Scholar
• 24. Nguyen A, Rauch TA, Pfeifer GP, Hu VW. Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain. FASEB J. 24(8), 3036–3051 (2010).
  Medline CASGoogle Scholar
• 25. James SJ, Shpyleva S, Melnyk S, Pavliv O, Pogribny IP. Complex epigenetic regulation of engrailed-2 (EN-2) homeobox gene in the autism cerebellum. Transl. Psychiatry 3(2), e232 (2013).
  Medline CASGoogle Scholar
• 26. Yahya SM, Gebril O, Raouf ERA, Elhadidy ME. A preliminary investigation of HTR1A gene expression levels in autism spectrum disorders. Int. J. Pharm. Pharm. Sci. 11(8), 1–3 (2019).
  CASGoogle Scholar
• 27. Emberti Gialloreti L, Mazzone L, Benvenuto A et al. Risk and protective environmental factors associated with autism spectrum disorder: evidence-based principles and recommendations. J. Clin. Med. 8(2), 217 (2019). • Updated overview of environmental factors linked to autism spectrum disorder.
  MedlineGoogle Scholar
• 28. Gallo R, Stoccoro A, Cagiano R et al. Correlation among maternal risk factors, gene methylation and disease severity in females with autism spectrum disorder. Epigenomics 14(4), 175–185 (2022).
  CASGoogle Scholar
• 29. Hu VW, Hong Y, Xu M, Shu HT. Altered DNA methylation in a severe subtype of idiopathic autism: evidence for sex differences in affected metabolic pathways. Autism 25(4), 887–910 (2021). • Interesting article showing sex-linked DNA methylation differences in autism spectrum disorder.
  MedlineGoogle Scholar
• 30. Calderoni S. Sex/gender differences in children with autism spectrum disorder: a brief overview on epidemiology, symptom profile, and neuroanatomy. J. Neurosci. Res. 10.1002/jnr.25000 (2022) (Epub ahead of print).
  MedlineGoogle Scholar
• 31. Buscema M, Grossi E, Snowdon D, Antuono P. Auto-Contractive Maps: an artificial adaptive system for data mining. An application to Alzheimer disease. Curr. Alzheimer Res. 5(5), 481–498 (2008). •• Interesting article detailing the Auto-Contractive Map (AutoCM) system.
  Medline CASGoogle Scholar
• 32. Coppedè F, Grossi E, Migheli F, Migliore L. Polymorphisms in folate-metabolizing genes, chromosome damage, and risk of Down syndrome in Italian women: identification of key factors using artificial neural networks. BMC Med. Genomics 3, 42 (2010).
  MedlineGoogle Scholar
• 33. Narzisi A, Muratori F, Buscema M, Calderoni S, Grossi E. Outcome predictors in autism spectrum disorders preschoolers undergoing treatment as usual: insights from an observational study using artificial neural networks. Neuropsychiatr. Dis. Treat. 11, 1587–1599 (2015).
  MedlineGoogle Scholar
• 34. Coppedè F, Grossi E, Lopomo A, Spisni R, Buscema M, Migliore L. Application of artificial neural networks to link genetic and environmental factors to DNA methylation in colorectal cancer. Epigenomics 7(2), 175–186 (2015).
  CASGoogle Scholar
• 35. Grossi E, Stoccoro A, Tannorella P, Migliore L, Coppedè F. Artificial neural networks link one-carbon metabolism to gene-promoter methylation in Alzheimer’s disease. J. Alzheimers Dis. 53(4), 1517–1522 (2016).
  Medline CASGoogle Scholar
• 36. Grossi E, Migliore L, Muratori F. Pregnancy risk factors related to autism: an Italian case–control study in mothers of children with autism spectrum disorders (ASD), their siblings and of typically developing children. J. Dev. Orig. Health Dis. 9(4), 442–449 (2018).
  Medline CASGoogle Scholar
• 37. Gallucci M, Pallucca C, Di Battista ME, Fougère B, Grossi E. Artificial neural networks help to better understand the interplay between cognition, Mediterranean diet, and physical performance: clues from TRELONG study. J. Alzheimers Dis. 71(4), 1321–1330 (2019).
  MedlineGoogle Scholar
• 38. Gagliano A, Galati C, Ingrassia M et al. Pediatric acute-onset neuropsychiatric syndrome: a data mining approach to a very specific constellation of clinical variables. J. Child Adolesc. Psychopharmacol. 30(8), 495–511 (2020).
  MedlineGoogle Scholar
• 39. Buscema M, Breda M, Lodwick W. Training With Input Selection and Testing (TWIST) algorithm: a significant advance in pattern recognition performance of machine learning. J. Intell. Learn. Syst. Appl. 5, 29–38 (2013). •• Interesting article detailing the TWIST system.
  Google Scholar
• 40. Buscema M, Newman F, Massini G, Grossi E, Liu AK. Assessing post radiotherapy treatment involving brain volume differences in children: an application of adaptive systems methodology. In: Data Mining Application Using Artificial Adaptive Systems. Tastle WJ (Ed.). Chapter 1, Springer Science-Business Media, NY, USA, 1–23 (2010). •• Interesting article detailing the Activation and Competition System (ACS).
  Google Scholar
• 41. Lord C, Rutter M, DiLavore et al. Autism Diagnostic Observation Schedule, Second Edition: ADOS-2 Modules 1–4. Western Psychological Services, CA, USA (2012).
  Google Scholar
• 42. Calderoni S, Ricca I, Balboni G et al. Evaluation of chromosome microarray analysis in a large cohort of females with autism spectrum disorders: a single center Italian study. J. Pers. Med. 10, 160 (2020).
  MedlineGoogle Scholar
• 43. Migheli F, Stoccoro A, Coppedè F et al. Comparison study of MS-HRM and pyrosequencing techniques for quantification of APC and CDKN2A gene methylation. PLOS ONE 8(1), e52501 (2013).
  Medline CASGoogle Scholar
• 44. Institute of Medicine (US) and National Research Council (US) Committee to Reexamine IOM Pregnancy Weight Guidelines. Weight Gain During Pregnancy: Reexamining the Guidelines. Rasmussen KMYaktine AL (Eds). National Academies Press (US), WA, USA (2009).
  Google Scholar
• 45. Buscema M. Genetic Doping Algorithm (GenD): theory and application. Expert Syst. 21, 63–79 (2004).
  Google Scholar
• 46. Eller-Vainicher C, Zhukouskaya VV, Tolkachev YV et al. Low bone mineral density and its predictors in type 1 diabetic patients evaluated by the classic statistics and artificial neural network analysis. Diabetes Care 34(10), 2186–2191 (2011).
  MedlineGoogle Scholar
• 47. Caffarra P, Gardini S, Dieci F et al. The qualitative scoring MMSE pentagon test (QSPT): a new method for differentiating dementia with Lewy body from Alzheimer’s disease. Behav. Neurol. 27(2), 213–220 (2013).
  MedlineGoogle Scholar
• 48. Coppedè F, Grossi E, Buscema M, Migliore L. Application of artificial neural networks to investigate one-carbon metabolism in Alzheimer’s disease and healthy matched individuals. PLOS ONE 8(8), e74012 (2013).
  Medline CASGoogle Scholar
• 49. Grossi E, Olivieri C, Buscema M. Diagnosis of autism through EEG processed by advanced computational algorithms: a pilot study. Comput. Methods Programs Biomed. 142, 73–79 (2017).
  MedlineGoogle Scholar
• 50. Ulivieri FM, Rinaudo L, Messina C et al. Bone Strain Index predicts fragility fracture in osteoporotic women: an artificial intelligence-based study. Eur. Radiol. Exp. 5(1), 47 (2021).
  MedlineGoogle Scholar
• 51. Vigna L, Silvia Tirelli A, Grossi E et al. Directional relationship between vitamin D status and prediabetes: a new approach from artificial neural network in a cohort of workers with overweight-obesity. J. Am. Coll. Nutr. 38(8), 681–692 (2019).
  Medline CASGoogle Scholar
• 52. Armstrong NC, Anderson RC, McDermott KW. Reelin: diverse roles in central nervous system development, health and disease. Int. J. Biochem. Cell Biol. 112, 72–75 (2019).
  Medline CASGoogle Scholar
• 53. Abdolmaleky HM, Cheng KH, Russo A et al. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am. J. Med. Genet. B Neuropsychiatr. Genet. 134B(1), 60–66 (2005).
  MedlineGoogle Scholar
• 54. Nabil Fikri RM, Norlelawati AT, Nour El-Huda AR et al. Reelin (RELN) DNA methylation in the peripheral blood of schizophrenia. J. Psychiatr. Res. 88, 28–37 (2017).
  MedlineGoogle Scholar
• 55. Alfimova MV, Kondratyev NV, Golov AK et al. Relationships of rs7341475 polymorphism and DNA methylation in the reelin gene with schizophrenia symptoms. Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova 118(9), 71–76 (2018).
  Medline CASGoogle Scholar
• 56. Alfimova MV, Kondratiev NV, Golov AK, Golimbet VE. Methylation of the reelin gene promoter in peripheral blood and its relationship with the cognitive function of schizophrenia patients. Mol. Biol. (Mosk.) 52(5), 782–792 (2018).
  Medline CASGoogle Scholar
• 57. Zhubi A, Chen Y, Guidotti A, Grayson DR. Epigenetic regulation of RELN and GAD1 in the frontal cortex (FC) of autism spectrum disorder (ASD) subjects. Int. J. Dev. Neurosci. 62, 63–72 (2017).
  Medline CASGoogle Scholar
• 58. James SJ, Shpyleva S, Melnyk S, Pavliv O, Pogribny IP. Elevated 5-hydroxymethylcytosine in the Engrailed-2 (EN-2) promoter is associated with increased gene expression and decreased MeCP2 binding in autism cerebellum. Transl. Psychiatry 4(10), e460 (2014).
  Medline CASGoogle Scholar
• 59. Good KV, Vincent JB, Ausió J. MeCP2: the genetic driver of Rett syndrome epigenetics. Front. Genet. 12, 620859 (2021).
  Medline CASGoogle Scholar
• 60. Lu Z, Liu Z, Mao W et al. Locus-specific DNA methylation of Mecp2 promoter leads to autism-like phenotypes in mice. Cell. Death Dis. 11(2), 85 (2020).
  Medline CASGoogle Scholar
• 61. Philippe TJ, Vahid-Ansari F, Donaldson ZR et al. Loss of MeCP2 in adult 5-HT neurons induces 5-HT1A autoreceptors, with opposite sex-dependent anxiety and depression phenotypes. Sci. Rep. 8(1), 5788 (2018).
  MedlineGoogle Scholar
• 62. Nawijn L, Krzyzewska IM, van Zuiden M et al. Oxytocin receptor gene methylation in male and female PTSD patients and trauma-exposed controls. Eur. Neuropsychopharmacol. 29(1), 147–155 (2019).
  Medline CASGoogle Scholar
• 63. Tian ZX, Wan M, Gao YL et al. Gestational weight gain and risk of autism spectrum disorders in offspring: a systematic review and meta-analysis. J. Obstet. Gynaecol. 40(7), 953–960 (2020).
  MedlineGoogle Scholar
• 64. Kheirouri S, Alizadeh M. Maternal excessive gestational weight gain as a risk factor for autism spectrum disorder in offspring: a systematic review. BMC Pregnancy Childbirth 20(1), 645 (2020).
  MedlineGoogle Scholar
• 65. Su L, Chen C, Lu L, Xiang AH, Dodds L, He K. Association between gestational weight gain and autism spectrum disorder in offspring: a meta-analysis. Obesity (Silver Spring) 28(11), 2224–2231 (2020).
  MedlineGoogle Scholar
• 66. Matias SL, Pearl M, Lyall K et al. Maternal prepregnancy weight and gestational weight gain in association with autism and developmental disorders in offspring. Obesity (Silver Spring) 29(9), 1554–1564 (2021).
  MedlineGoogle Scholar
• 67. Yu X, Rahman MM, Wang Z et al. Evidence of susceptibility to autism risks associated with early life ambient air pollution: a systematic review. Environ. Res. 208, 112590 (2022).
  Medline CASGoogle Scholar
• 68. Rahman MM, Shu YH, Chow T et al. Prenatal exposure to air pollution and autism spectrum disorder: sensitive windows of exposure and sex differences. Environ. Health Perspect. 130(1), 17008 (2022).
  Medline CASGoogle Scholar
• 69. Miani A, Imbriani G, De Filippis G et al. Autism spectrum disorder and prenatal or early life exposure to pesticides: a short review. Int. J. Environ. Res. Public Health 18(20), 10991 (2021).
  Medline CASGoogle Scholar
• 70. von Ehrenstein OS, Ling C, Cui X et al. Prenatal and infant exposure to ambient pesticides and autism spectrum disorder in children: population based case–control study. BMJ 364, l962 (2019).
  MedlineGoogle Scholar
• 71. Alvarez-Fischer D, Fuchs J, Castagner F et al. Engrailed protects mouse midbrain dopaminergic neurons against mitochondrial complex I insults. Nat. Neurosci. 14(10), 1260–1266 (2011).
  Medline CASGoogle Scholar
• 72. Han W, Dong X, Song X et al. Effects of advanced maternal age on cognitive and emotional development in offspring rats. Behav. Brain Res. 353, 218–226 (2018).
  MedlineGoogle Scholar
• 73. Bayrampour H, Heaman M. Advanced maternal age and the risk of cesarean birth: a systematic review. Birth 37(3), 219–226 (2010).
  MedlineGoogle Scholar
• 74. Rydahl E, Declercq E, Juhl M, Maimburg RD. Cesarean section on a rise – does advanced maternal age explain the increase? A population register-based study. PLOS ONE 14(1), e0210655 (2019).
  Medline CASGoogle Scholar
• 75. Huang K, Hu Y, Sun Y et al. Elective caesarean delivery and offspring’s cognitive impairment: implications of methylation alteration in hippocampus glucocorticoid signaling genes. Brain Res. Bull. 144, 108–121 (2019).
  Medline CASGoogle Scholar
• 76. Chen H, Lombès M, Le Menuet D. Glucocorticoid receptor represses brain-derived neurotrophic factor expression in neuron-like cells. Mol. Brain 10(1), 12 (2017).
  MedlineGoogle Scholar
• 77. Blaze J, Asok A, Borrelli K et al. Intrauterine exposure to maternal stress alters Bdnf IV DNA methylation and telomere length in the brain of adult rat offspring. Int. J. Dev. Neurosci. 62, 56–62 (2017).
  Medline CASGoogle Scholar
• 78. Niknazar S, Nahavandi A, Peyvandi AA, Peyvandi H, Zare Mehrjerdi F, Karimi M. Effect of maternal stress prior to conception on hippocampal BDNF signaling in rat offspring. Mol. Neurobiol. 54(8), 6436–6445 (2017).
  Medline CASGoogle Scholar
• 79. Kertes DA, Bhatt SS, Kamin HS, Hughes DA, Rodney NC, Mulligan CJ. BNDF methylation in mothers and newborns is associated with maternal exposure to war trauma. Clin. Epigenetics 9, 68 (2017).
  MedlineGoogle Scholar
• 80. Unternaehrer E, Meyer AH, Burkhardt SC et al. Childhood maternal care is associated with DNA methylation of the genes for brain-derived neurotrophic factor (BDNF) and oxytocin receptor (OXTR) in peripheral blood cells in adult men and women. Stress 18(4), 451–461 (2015).
  MedlineGoogle Scholar